Interpretation of Cerebrospinal Fluid Protein Tests in the Diagnosis of Sporadic Creutzfeldt-Jakob Disease: an Evidence-based Approach

Overview

Journal CMAJ

Date 2014 Jan 22

PMID 24446456

Citations 5

Authors

Michael B Coulthart

Gerard H Jansen

Neil R Cashman

Affiliations

Soon will be listed here.

Citing Articles

Creutzfeldt-Jakob disease: A case report.

Butt F, Dhivagaran T, Naqvi S Radiol Case Rep. 2024; 20(2):1095-1098.

PMID: 39687838 PMC: 11647126. DOI: 10.1016/j.radcr.2024.11.011.

Atypical Presentation of Probable Sporadic Creutzfeldt-Jakob Disease: A Patient Without Mental Deterioration.

Nisa N, Inam N, Stewart C, Sukpraprut-Braaten S Cureus. 2024; 16(7):e64814.

PMID: 39156438 PMC: 11330293. DOI: 10.7759/cureus.64814.

Creutzfeldt-Jakob Disease: An Unusual Presentation of Corticobasal Syndrome.

Gosden G, Okromelidze L, Sandhu S, Middlebrooks E Cureus. 2020; 12(11):e11393.

PMID: 33312792 PMC: 7725196. DOI: 10.7759/cureus.11393.

Creutzfeldt-Jakob disease: The search for definitive diagnostic tests continues.

Coulthart M, Ances B Neurol Clin Pract. 2018; 5(2):99-101.

PMID: 29443203 PMC: 5764443. DOI: 10.1212/CPJ.0000000000000103.

Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease.

Cheng K, Vendramelli R, Sloan A, Waitt B, Podhorodecki L, Godal D J Clin Microbiol. 2016; 54(7):1751-1754.

PMID: 27076662 PMC: 4922112. DOI: 10.1128/JCM.00542-16.

References

Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers D, Almonti S . MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009; 72(23):1994-2001. DOI: 10.1212/WNL.0b013e3181a96e5d. View

Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs Jr C . An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol. 2000; 48(3):395-8. View

Vickrey B, Samuels M, Ropper A . How neurologists think: A cognitive psychology perspective on missed diagnoses. Ann Neurol. 2010; 67(4):425-33. DOI: 10.1002/ana.21907. View

Kovacs G, Voigtlander T, Gelpi E, Budka H . Rationale for diagnosing human prion disease. World J Biol Psychiatry. 2004; 5(2):83-91. DOI: 10.1080/15622970410029916. View

Vitali P, Maccagnano E, Caverzasi E, Henry R, Haman A, Torres-Chae C . Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011; 76(20):1711-9. PMC: 3100134. DOI: 10.1212/WNL.0b013e31821a4439. View

Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D . Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011; 17(2):175-8. DOI: 10.1038/nm.2294. View

Coulthart M, Jansen G, Olsen E, Godal D, Connolly T, Choi B . Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol. 2011; 11:133. PMC: 3216246. DOI: 10.1186/1471-2377-11-133. View

Mulherin S, Miller W . Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med. 2002; 137(7):598-602. DOI: 10.7326/0003-4819-137-7-200210010-00011. View

Attia J, Nair B, Sibbritt D, Ewald B, Paget N, Wellard R . Generating pre-test probabilities: a neglected area in clinical decision making. Med J Aust. 2004; 180(9):449-54. DOI: 10.5694/j.1326-5377.2004.tb06020.x. View

10.

Collins S, Boyd A, Fletcher A, Gonzales M, McLean C, Byron K . Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. J Clin Neurosci. 2000; 7(3):203-8. DOI: 10.1054/jocn.1999.0193. View

11.

Pauker S, Kassirer J . The threshold approach to clinical decision making. N Engl J Med. 1980; 302(20):1109-17. DOI: 10.1056/NEJM198005153022003. View

12.

Wang G, Gao C, Shi Q, Zhou W, Chen J, Dong C . Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease. Am J Med Sci. 2010; 340(4):291-5. DOI: 10.1097/MAJ.0b013e3181e92a1f. View

13.

Belay E, Schonberger L . The public health impact of prion diseases. Annu Rev Public Health. 2005; 26:191-212. DOI: 10.1146/annurev.publhealth.26.021304.144536. View

14.

Rabinovici G, Wang P, Levin J, Cook L, Pravdin M, Davis J . First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006; 66(2):286-7. DOI: 10.1212/01.wnl.0000196440.00297.67. View

15.

Schott J, Reiniger L, Thom M, Holton J, Grieve J, Brandner S . Brain biopsy in dementia: clinical indications and diagnostic approach. Acta Neuropathol. 2010; 120(3):327-41. DOI: 10.1007/s00401-010-0721-y. View

16.

Meiner Z, Kahana E, Baitcher F, Korczyn A, Chapman J, Cohen O . Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol. 2010; 258(2):255-62. DOI: 10.1007/s00415-010-5738-6. View

17.

Carswell C, Thompson A, Lukic A, Stevens J, Rudge P, Mead S . MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol. 2012; 12:153. PMC: 3604954. DOI: 10.1186/1471-2377-12-153. View

18.

Mackay G, Knight R, Ironside J . The molecular epidemiology of variant CJD. Int J Mol Epidemiol Genet. 2011; 2(3):217-27. PMC: 3166149. View

19.

Brown P . Transmissible spongiform encephalopathy in the 21st century: neuroscience for the clinical neurologist. Neurology. 2008; 70(9):713-22. DOI: 10.1212/01.wnl.0000302186.10596.f6. View

20.

Collins S, Sanchez-Juan P, Masters C, Klug G, van Duijn C, Poleggi A . Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006; 129(Pt 9):2278-87. DOI: 10.1093/brain/awl159. View